Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Provention Bio Inc (NQ: PRVB )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Provention Bio Inc

< Previous 1 2 3 4 5 6 7 8 Next >
PRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is First Republic Bank (FRC) Stock Down 61% Today?
First Republic Bank (FRC) stock is falling hard on Monday as bank stocks react to the recent drama surrounding SVB Financial (SIVB). 
Via InvestorPlace
Why Provention Bio Stock Is Rocketing Past 52-Week Highs Today
Provention Bio Inc (NASDAQ: PRVB) shares are rocketing higher Monday after Sanofi (NASDAQ: SNY) announced plans to acquire the biopharmaceutical company. 
Via Benzinga
Why Is Science 37 (SNCE) Stock Up 9% Today?
Science 37 (SNCE) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. 
Via InvestorPlace
Analyst Expectations for Provention Bio's Future
Via Benzinga
Why Shares of Provention Bio Went Up 30.3% in November
The company got approval for its lead type 1 diabetes therapy. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Provention Bio
Via Benzinga
Provention Bio (PRVB) Stock Falls Despite FDA Approval
Provention Bio is celebrating a milestone medical moment. Yet, PRVB stock is falling because an important drug may be overpriced. 
Via InvestorPlace
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of... 
Via Benzinga
Why Is Provention Bio (PRVB) Stock Up 263% Today?
Provention Bio (PRVB) stock is rocketing higher on Monday following news that Sanofi (SNY) is acquiring the company for $2.9 billion. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday! 
Via InvestorPlace
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis. 
Via Benzinga
Why Shares of MacroGenics Jumped Thursday
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy. 
Via The Motley Fool
2 Beaten-Down Stocks That Might Be too Cheap to Ignore
There is an argument for hitting the buy button, but it's important to consider the potential risks too. 
Via The Motley Fool
IAC To Rally Around 40%? Here Are 10 Other Analyst Forecasts For Wednesday
Mizuho boosted the price target for SoFi Technologies, Inc. (NASDAQ: SOFI) from $6 to $9.. Goldman Sachs analyst Emily Chieng maintained a Sell rating on the stock. SoFi Technologies shares fell 0.6%... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Is This Biotech Stock a Buy Following a Landmark Approval?
You may not want to be too quick to pull the trigger. 
Via The Motley Fool
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%. 
Via Benzinga
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
  Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 68 companies reached new 52-week highs. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
Via Benzinga
TSLA Stock Alert: Tesla Recalls 30,000 EVs for Airbag Issue
Tesla (TSLA) stock is in the news Friday as investors react to the electric vehicle company (EV) recalling 30,000 units due to airbag issues. 
Via InvestorPlace
Why Did Ticketmaster Cancel Taylor Swift Ticket Sales?
Ticketmaster is caught up in drama after it had to cancel sales of Taylor Swift tickets due to problems with its website. 
Via InvestorPlace
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Three Months Wait Time For Twitter Blue Mark Verification, Zuckerberg's WhatsApp And Metaverse Plans, China's COVID-19 Measures Hurt Alibaba's Biggest Event: Top Stories Friday, Nov. 18
Reuters 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.